"Anti-Mullerian Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.
| Descriptor ID |
D054304
|
| MeSH Number(s) |
D06.472.334.984.500
|
| Concept/Terms |
Anti-Mullerian Hormone- Anti-Mullerian Hormone
- Anti Mullerian Hormone
- Antimullerian Hormone
- Mullerian Inhibiting Hormone
- Mullerian Inhibiting Substance
- Mullerian-Inhibitory Substance
- Mullerian Inhibitory Substance
- Mullerian-Inhibiting Factor
- Mullerian Inhibiting Factor
- Mullerian-Inhibiting Hormone
- Anti-Mullerian Factor
- Anti Mullerian Factor
- Mullerian Regression Factor
|
Below are MeSH descriptors whose meaning is more general than "Anti-Mullerian Hormone".
Below are MeSH descriptors whose meaning is more specific than "Anti-Mullerian Hormone".
This graph shows the total number of publications written about "Anti-Mullerian Hormone" by people in this website by year, and whether "Anti-Mullerian Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Mullerian Hormone" by people in Profiles.
-
Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma--evaluation by using antim?llerian hormone and retrieved oocytes. Fertil Steril. 2012 Jul; 98(1):141-4.
-
Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus. 2011 Oct; 20(11):1193-7.
-
Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011 Jun 10; 29(17):2334-41.
MeSH information
